Brain Metabolism Observed at 3 Tesla or 7 Tesla in Health and Metabolic Disease
NCT05085704
This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .
Summary
The goal is to develop methodology to monitor flux in the citric acid cycle in brain via 13C nuclear magnetic resonance (NMR) spectroscopy at 7 Tesla or 3 Tesla.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Glut1 Deficiency Syndrome 1
- Glucose Metabolism Disorders
- Epilepsy
- Glut1 Deficiency Syndrome 1, Autosomal Recessive
- Glucose Transporter Type 1 Deficiency Syndrome
- Glucose Transporter Protein Type 1 Deficiency Syndrome
- Glucose Transport Defect
Eligibility basics and study details
- Study type
- Observational
- Phase
- Not applicable
- Ages
- 16 to 80 years
- Sex
- All
- Healthy volunteers
- Accepted
- Sponsor
- Weill Medical College of Cornell University
- Last updated on ClinicalTrials.gov
- June 1, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
New York · 1
- Weill Cornell Medicine · New York, NY
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.